PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 1, 2002Journal of Clinical Investigation112 citationsOpen Access

Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis

KSKen‐ichiro SasakiTMToyoaki MuroharaHIHisao Ikeda

Key Result

Angiotensin II type 1a receptor deficiency or pharmacological blockade significantly impaired ischemia-induced angiogenesis and blood flow recovery in a mouse model of hindlimb ischemia.

PICO

P
Population
Hindlimb ischemia
I
Intervention / Comparator
AT1a receptor deficiency or TCV-116 (AT1 receptor blocker) vs Wild-type mice (TCV-116 5 mg/kg/d)
O
Primary Outcome
Ischemic/normal hindlimb blood flow ratio, p=<0.05

Main Result

p-value: p=<0.05

Limitations

  • The dose of TCV-116 was higher than the clinical dose.
  • In several experimental groups, only laser Doppler blood flow values were measured to assess ischemia-induced angiogenesis.
  • Western blot analysis of homogenized tissue extracts does not address potential differences in skeletal muscle VEGF expression.

Abstract

stem cells with a targeted

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Sasaki et al. (2002) studied Hindlimb ischemia. AT1a receptor deficiency or TCV-116 (AT1 receptor blocker) vs. Wild-type mice was evaluated on Ischemic/normal hindlimb blood flow ratio (p=<0.05). Angiotensin II type 1a receptor deficiency or pharmacological blockade significantly impaired ischemia-induced angiogenesis and blood flow recovery in a mouse model of hindlimb ischemia.

synapsesocial.com/papers/6a1d9c0ccc9f7df1b705b22ahttps://doi.org/10.1172/jci0213055
Ask AI
Helpful
Bookmark
Share
View Full Paper